References
- FusterVRydénLECannomDSAmerican College of Cardiology/American Heart Association Task Force on Practice GuidelinesEuropean Society of Cardiology Committee for Practice GuidelinesEuropean Heart Rhythm AssociationHeart Rhythm SocietyACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm SocietyCirculation2006114e257e35416908781
- RosenthalLAtrial fibrillationeMedicine (online) Available from: http://emedicine.medscape.com/article/151066-overview#showallAccessed January 3, 2013
- MiyasakaYBarnesMEGershBJSecular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalenceCirculation200611411912516818816
- AnsellJHirshJHylekEJacobsonACrowtherMPalaretiGAmerican College of Chest PhysiciansPharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines8th edChest2008133160S198S18574265
- ConnollySJEzekowitzMDYusufSRE-LY Steering Committee and InvestigatorsDabigatran versus warfarin in patients with atrial fibrillationN Engl J Med20093611139115119717844
- GrangerCBAlexanderJHMcMurrayJJARISTOTLE Committees and InvestigatorsApixaban versus warfarin in patients with atrial fibrillationN Engl J Med201136598199221870978
- PatelMRMahaffeyKWGargJROCKET AF InvestigatorsRivaroxaban versus warfarin in nonvalvular atrial fibrillationN Engl J Med201136588389121830957
- Coumadin [package insert]Princeton, NJ, USABristol Myers Squibb2010
- HillemanDENew oral anticoagulants for stroke prevention in atrial fibrillationAm J Pharm Benefits20124269283
- Boehringer IngelheimUS FDA approves Pradaxa® (dabigatran etexilate) – a breakthrough treatment for stroke risk reduction in non-valvular atrial fibrillation Available from: http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2010/20_october_2010_dabigatran.htmlAccessed December 24, 2012
- US Food and Drug AdministrationFDA approves Xarelto to prevent stroke in people with common type of abnormal heart rhythm Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm278646.htmAccessed December 24, 2012
- WarnerJFDA approves new blood thinner Eliquis Available from: http://www.webmd.com/heart-disease/atrial-fibrillation/news/20121231/fda-blood-thinner-eliquisAccessed March 8, 2013
- FraserAThe Short-Term Leeds Dyspepsia Questionnaire validation studyAliment Pharmacol Ther20072547748617270004